Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactoferrin for H. Pylori Eradication in Egyptian Patients
NCT04445948Phase 4Completed
- Sponsor
- Alexandria University
- Start
- Nov 2019
- Primary completion
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of lactoferrin in Helicobacter pylori infection, sponsored by Alexandria University. Started Nov 2019; status: completed.
02
Drugs
lactoferrin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04445948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04445948.